Tuesday, July 2, 2019 Expanded Testing for Gonorrhea and Chlamydia Findings from a NIAID-funded study informed the FDA's recent decision to approve two diagnostic tests for use in detecting gonorrhea and chlamydia infections in the pharynx (throat) and rectum. Now the tests may be more readily available to clinics across the country, helping to curb transmission of potentially drug-resistant infections. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107